Mitral Regurgitation is the third most common cardiovascular disease that occurs when there is backward flow of blood across the mitral valve. It is highly prevalent, debilitating for patients, and deadly if untreated. The market is expected to be larger than the TAVR market, currently a $6B market.\u003cbr />\u003cbr />The CardioMech device is an artificial chord that is designed to reduce or eliminate regurgitation and to restore the native anatomy. This catheter-based therapy is intended to be a simple and straightforward procedure and an alternative therapy option for both patients eligible for open-heart surgery and those considered surgically ineligible. Therefore, the CardioMech device can potentially reduce the need for open-heart surgery and may lessen the need for watchful waiting in younger and healthier patients.\u003cbr />\u003cbr />Caution: Investigational device. Limited by law to investigational use.\u003cbr />\u003c/p>","textEditorHeight":437},"type":"text","cl":"text LcLAwx6FL"},{"key":"e3kmsUavjxz","content":{"videoId":{"thumbnail":"https://i.vimeocdn.com/video/552589225_640","title":"Endovascular insertion of neo-chords","duration":90,"id":152559672,"desc":"With CardioMech's new endovascular device, insertion of neo-chords can be accomplished safely without open surgery. Note: The CardioMech device is under pre-clinical testing and is not available for clinical use. www.cardiomech.com"},"color":"ff0033","autopause":true,"autoplay":false},"type":"w73box3z","cl":"w73box3z"},{"key":"e2PPvYOA0T","type":"section","children":["en96rIMVOF","e3kmsUavjxz"],"cl":"section"},{"key":"e-K9kuDRAA","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"edOM2y7Sj9","content":{"text":"\u003cblockquote>CardioMech develops the next generation of interventional devices for structural heart disease.\u003c/blockquote>","origin":[0.5,0.5],"textEditorHeight":248},"type":"text","actions":["e-K9kuDRAA"],"cl":"text LcLAwx6FL"},{"key":"ecZ1UYpN5N","content":{"speed":40},"type":"w1c3kqru4r-1p7v","children":["edOM2y7Sj9"],"cl":"w1c3kqru4r-1p7v"},{"key":"endrLNXWdO","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"e2B0fyijjz","content":{"text":"\u003cp >\u003c/p>\u003ch2 >Leadership Team\u003c/h2>\u003cp >\u003cbr />\u003cbr />\u003cstrong >Rick Nehm, President and CEO, Chairman BOD,\u003c/strong> is a seasoned medical device professional in the structural heart market with nearly 20 years of leadership experience in sales, marketing and business development across large and small companies. His expertise in product development and commercialization within interventional cardiology, cardiac surgery and structural heart will help drive the development of the CardioMech program. Rick previously held leadership roles with\u003cstrong > Boston Scientific Corp., Tendyne Holdings Inc. (Abbott) and ATS Medical (Medtronic).\u003c/strong>\u003cbr />\u003c/p>","textEditorHeight":353},"type":"text","actions":["endrLNXWdO"],"cl":"text LcLAwx6FL"},{"key":"e1QmHzqRhE","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"ee6Ratbzum","content":{"text":"\u003cp>\u003cstrong>John Blix, Chief Operation Officer\u003c/strong>\u003cem>\u003cstrong>,\u003c/strong>\u003c/em>\u003cstrong> \u003c/strong>has over 20 years of medical device experience at increasing levels of responsibility in development of implants, catheters, capital equipment and software. John brings a rare combination of successful project leadership with hands-on technical expertise. He has a background spanning the full spectrum of product development including research and development, project and program management, process development, manufacturing and quality efforts. He has successfully led development in Class II and Class III products for interventional cardiology, peripheral vascular, interventional radiology, renal denervation and electrophysiology markets. John has a successful track record of bringing over 30 product to market, including 7 that he led from concept to commercialization. John has over 29 issued patents across a broad range of technologies and has earned multiple recognition awards for his technical and commercial contributions for top medical device companies.\u003cbr/>\u003c/p>","textEditorHeight":185},"type":"text","actions":["e1QmHzqRhE"],"cl":"text LcLAwx6FL"},{"key":"euIuN3xBAN","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"eOhb9WZPF-l","content":{"src":{"url":"https://cdn.vev.design/private/nx4PIJZC5DRvGj91MUsleDCILln2/images/_3FhYmqxQ/2100.jpg","key":"_3FhYmqxQ","ratio":0.66640625}},"type":"image","actions":["euIuN3xBAN"],"cl":"image"},{"key":"eNDN0MICKrg","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"ecVA3k1XN_G","content":{"src":{"url":"https://a.vev.design/r/hFf5FHwjM_2100_jpeg.jpg","key":"hFf5FHwjM","ratio":1.5009380863039399}},"type":"image","actions":["eNDN0MICKrg"],"cl":"image"},{"key":"epr7vaU15dQ","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"eMZSYlKWFC","content":{"text":"\u003cp>\u003cbr/>\u003cstrong>Daniele Salamone, CFO,\u003c/strong> is an experienced strategy consultant with expertise in Corporate Development - both strategic planning and M&A transactions - and Innovation - both Start-ups and Corporate Innovation. He has direct experience in structural heart commercialization and his expertise and investor-friendly perspective will help accelerate the CardioMech program to build shareholder value. Daniele most recently worked at The Boston Consulting Group. \u003cbr/>\u003cbr/>\u003c/p>","textEditorHeight":219},"type":"text","actions":["epr7vaU15dQ"],"cl":"text LcLAwx6FL"},{"key":"enQbKRVnlxi","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"en7s6dMkJ-z","content":{"src":"SBIi_XLEN"},"type":"image","actions":["enQbKRVnlxi"],"cl":"image"},{"key":"eBA-kYbp3MH","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"eaFCMzzyN6","content":{"text":"\u003cp>\u003cstrong>\u003cbr/>Nikolai Hiorth, Founder, CTO\u003c/strong>, is an innovative and award winning mechanical engineer with expertise across multiple medical device and high tech domains. Nikolai co-invented DIGNUM, a CE approved device that allows patients with paralysis to live independently and is also the co-founder of CardioMech. His passion for solving challenging problems is rooted in his early days on the job site with his architect father, making countless prototypes and building extreme sports equipment, including making an electric hydrofoil, a flying surfboard together with his brother Hans.\u003cbr/>\u003c/p>","textEditorHeight":219},"type":"text","actions":["eBA-kYbp3MH"],"cl":"text LcLAwx6FL"},{"key":"eBzV2HJWINn","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"epHDz4aWP3L","content":{"src":{"url":"https://a.vev.design/r/sJccsJz7O_2100.jpg","key":"sJccsJz7O","ratio":0.6666666666666666}},"type":"image","actions":["eBzV2HJWINn"],"cl":"image"},{"key":"efVelNBIiBS","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"eRBCp-rSJA","content":{"src":{"url":"https://a.vev.design/r/1U06exkDR_2100.png","key":"1U06exkDR","ratio":0.9665551839464883}},"type":"image","actions":["efVelNBIiBS"],"cl":"image"},{"key":"eK6yhnUX1wi","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"eo_RtiiJmRl","content":{"text":"\u003cp >\u003cstrong >Jacob Bergsland, Founder, CMO, BOD\u003c/strong>, was born in California, grew up in Norway and returned to the US to become a cardiac surgeon. During his work in Buffalo, NY, he worked as a clinical and academic surgeon and was essential in initiating cardiac transplantation and minimally invasive cardiac surgery in the city. In the 90’s he worked as a war-surgeon for the United Nations during the war in Bosnia where he established the first cardiac center in the country with local doctors. Jacob has\\ worked for more than 10 years at the Intervention Center of the Oslo University Hospital, a Center for developing new methods and equipment for minimally invasive surgery and interventional therapies.\u003c/p>","textEditorHeight":390},"type":"text","actions":["eK6yhnUX1wi"],"cl":"text LcLAwx6FL"},{"key":"e_xx6UW8kEt","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"ea2Y0vdmwe","content":{"text":"\u003cp>\u003cstrong>Hans Hiorth, Senior Development Engineer,\u003c/strong> Innovative mechanical engineer with a passion for problem solving. Experienced in bringing ideas to working products. From a family of talented engineers and the brother of founder Nikolai Hiorth. Hans has been involved with Cardiomech from the very beginning, building the first devices in the garage 6 years ago, making the foundation for today’s technology. When Nikolai needed more staff, the natural choice fell upon Hans. Since then he has been a significant asset bringing the technology forward.\u003c/p>","textEditorHeight":219},"type":"text","actions":["e_xx6UW8kEt"],"cl":"text LcLAwx6FL"},{"key":"ediqFv0NpMA","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"eKvDGjSBhkl","content":{"src":{"url":"https://cdn.vev.design/private/nx4PIJZC5DRvGj91MUsleDCILln2/images/aNuySzFkW/2100.jpg","key":"aNuySzFkW","ratio":0.8957286432160804}},"type":"image","actions":["ediqFv0NpMA"],"cl":"image"},{"key":"em-PTp14P6","type":"section","children":["e2B0fyijjz","ee6Ratbzum","eOhb9WZPF-l","ecVA3k1XN_G","eMZSYlKWFC","en7s6dMkJ-z","eaFCMzzyN6","epHDz4aWP3L","eRBCp-rSJA","eo_RtiiJmRl","ea2Y0vdmwe","eKvDGjSBhkl"],"cl":"section"},{"key":"etMQ9uxKxTX","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"eqcMLeZkji","content":{"text":"\u003cp>\u003cstrong>Vic Bertrand\u003c/strong> is a seasoned consumer products entrepreneur and investor with over 30 years of investing and business experience across innovation product development, manufacturing, licensing and marketing. He has expertise as an active board director, currently serving on five Board of Directors, three of which are medical device companies. Vic is currently the President of Strainn Inc.\u003cstrong> \u003c/strong>(Investment and Real Estate company) and he has previously held leadership roles at Mega Brands Inc.\u003c/p>","textEditorHeight":181},"type":"text","actions":["etMQ9uxKxTX"],"cl":"text LcLAwx6FL"},{"key":"eQCJBD6p_V","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"e9aFZYwhtV","content":{"text":"\u003cp >\u003cstrong >Jacob Bergsland, Founder, CMO, BOD\u003c/strong>, was born in California, grew up in Norway and returned to the US to become a cardiac surgeon. During his work in Buffalo, NY, he worked as a clinical and academic surgeon and was essential in initiating cardiac transplantation and minimally invasive cardiac surgery in the city. In the 90’s he worked as a war-surgeon for the United Nations during the war in Bosnia where he established the first cardiac center in the country with local doctors. Jacob has\\ worked for more than 10 years at the Intervention Center of the Oslo University Hospital, a Center for developing new methods and equipment for minimally invasive surgery and interventional therapies.\u003cbr />\u003cbr />\u003c/p>","textEditorHeight":224},"type":"text","actions":["eQCJBD6p_V"],"cl":"text LcLAwx6FL"},{"key":"eo2KdTRQHs","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"eK2EydwO-vb","content":{"src":{"src":"https://a.vev.design/r/1U06exkDR_2100.png","key":"1U06exkDR"}},"type":"image","actions":["eo2KdTRQHs"],"cl":"image"},{"key":"es-AQ2NOJzX","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"e2WjXsqZtp","content":{"text":"\u003cp >\u003c/p>\u003ch2 >Board of Directors\u003c/h2>\u003cp >\u003cstrong >\u003cbr />\u003cbr />Rick Nehm, President and CEO, Chairman BOD,\u003c/strong> is a seasoned medical device professional in the structural heart market with nearly 20 years of leadership experience in sales, marketing and business development across large and small companies. His expertise in product development and commercialization within interventional cardiology, cardiac surgery and structural heart will help drive the development of the CardioMech program. Rick previously held leadership roles with\u003cstrong > Boston Scientific Corp., Tendyne Holdings Inc. (Abbott) and ATS Medical (Medtronic).\u003c/strong>\u003cbr />\u003c/p>","textEditorHeight":410},"type":"text","actions":["es-AQ2NOJzX"],"cl":"text LcLAwx6FL"},{"key":"eFyClWCYQtk","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"eWaTRZcCpJL","content":{"src":"SBIi_XLEN"},"type":"image","actions":["eFyClWCYQtk"],"cl":"image"},{"key":"eTC627in3q","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"eplCwHFVXBj","content":{"src":"ns6ZAda5C"},"type":"image","actions":["eTC627in3q"],"cl":"image"},{"key":"ewekOg7_N1","type":"section","children":["eqcMLeZkji","e9aFZYwhtV","eK2EydwO-vb","e2WjXsqZtp","eWaTRZcCpJL","eplCwHFVXBj"],"cl":"section"},{"key":"eryWX_pwP4","content":{"hide":1,"time":1.25,"dist":10},"type":"w729zbwl","icons":{"slide":[320,512,"M168.5 84.2l148 146.8c4.7 4.7 4.7 12.3 0 17l-19.8 19.8c-4.7 4.7-12.3 4.7-17 0L160 149.3 40.3 267.8c-4.7 4.7-12.3 4.7-17 0L3.5 248c-4.7-4.7-4.7-12.3 0-17l148-146.8c4.7-4.7 12.3-4.7 17 0zm-17 160L3.5 391c-4.7 4.7-4.7 12.3 0 17l19.8 19.8c4.7 4.7 12.3 4.7 17 0L160 309.3l119.7 118.5c4.7 4.7 12.3 4.7 17 0l19.8-19.8c4.7-4.7 4.7-12.3 0-17l-148-146.8c-4.7-4.7-12.3-4.7-17 0z"]},"cl":"w729zbwl"},{"key":"epkRn98xrIm","content":{"src":"ZhIfiiGgr","origin":[0.5,0]},"type":"image","actions":["eryWX_pwP4"],"cl":"image"},{"key":"eSkz9c0rs7","content":{"text":"\u003cp>\u003cbr/>\u003c/p>\u003ch2>Partners\u003c/h2>\u003cp>\u003cbr/>\u003cbr/>\u003cbr/>\u003c/p>","textEditorHeight":239},"type":"text","cl":"text LcLAwx6FL"},{"key":"eIsk--hEz_","type":"section","children":["epkRn98xrIm","eSkz9c0rs7"],"cl":"section"},{"key":"eSk5qWeLs7","content":{"text":"\u003ch3>General inqueries\u003c/h3>\u003cp>\u003ca href=\"mailto:info@cardiomech.com\" target=\"_self\" data-link-mode=\"2\">info@cardiomech.com\u003c/a>\u003cbr/>CardioMech AS\u003cbr/>7030 Trondheim\u003cbr/>Norway\u003c/p>","textEditorHeight":167},"type":"text","cl":"text B1ltIl8iX"},{"key":"eByShQeLsQ","content":{"src":"78is4PxGP","origin":[0,1]},"type":"image","cl":"image"},{"key":"eBkTC7eIjX","content":{"text":"\u003cp>CardioMech AS © 2018 · All rights reserved\u003c/p>","origin":[0,1],"textEditorHeight":56},"type":"text","cl":"text"},{"key":"epLGOXhzoy","content":{"origin":[1,0]},"type":"w1bn5r0s80-1477","cl":"w1bn5r0s80-1477"},{"key":"eE2SfdxeMQ","type":"section","children":["eSk5qWeLs7","eByShQeLsQ","eBkTC7eIjX","epLGOXhzoy"],"cl":"section"},{"key":"dzmMJEvXwR","children":["eZ98HwH_JE","e2PPvYOA0T","ecZ1UYpN5N","em-PTp14P6","ewekOg7_N1","eIsk--hEz_","eE2SfdxeMQ"]}],"pages":[{"key":"GbXmvMKqP","title":"Press","desc":"Press release cardiomech ","cover":"undefined/image/social/undefined/GbXmvMKqP/v/0.jpg","path":"press"},{"key":"NPVO3Pr1M","title":"Monsoon","cover":"undefined/image/social/undefined/NPVO3Pr1M/v/0.jpg","path":"monsoon"},{"key":"dzmMJEvXwR","title":"Cardiomech","desc":"Designing new therapeutic options for heart disease","cover":"https://a.vev.design/r/A1upBLM7z_500.jpg","path":"","index":true}],"shapes":{},"images":{"1U06exkDR":{"meta":{"width":289,"height":299},"src":"https://a.vev.design/r/1U06exkDR_2100.png","srcset":[["https://a.vev.design/r/1U06exkDR_300.png",300],["https://a.vev.design/r/1U06exkDR_500.png",500],["https://a.vev.design/r/1U06exkDR_1080.png",1080],["https://a.vev.design/r/1U06exkDR_1600.png",1600],["https://a.vev.design/r/1U06exkDR_2100.png",2100]]},"78is4PxGP":{"meta":{"width":632,"height":485},"src":"https://a.vev.design/r/78is4PxGP_2100.png","srcset":[["https://a.vev.design/r/78is4PxGP_300.png",300],["https://a.vev.design/r/78is4PxGP_500.png",500],["https://a.vev.design/r/78is4PxGP_1080.png",1080],["https://a.vev.design/r/78is4PxGP_1600.png",1600],["https://a.vev.design/r/78is4PxGP_2100.png",2100]]},"SBIi_XLEN":{"meta":{"width":3008,"height":4512},"src":"https://a.vev.design/r/SBIi_XLEN_2100.jpg","srcset":[["https://a.vev.design/r/SBIi_XLEN_300.jpg",300],["https://a.vev.design/r/SBIi_XLEN_500.jpg",500],["https://a.vev.design/r/SBIi_XLEN_1080.jpg",1080],["https://a.vev.design/r/SBIi_XLEN_1600.jpg",1600],["https://a.vev.design/r/SBIi_XLEN_2100.jpg",2100]]},"ZhIfiiGgr":{"meta":{"width":1000,"height":363},"src":"https://a.vev.design/r/ZhIfiiGgr_2100.png","srcset":[["https://a.vev.design/r/ZhIfiiGgr_300.png",300],["https://a.vev.design/r/ZhIfiiGgr_500.png",500],["https://a.vev.design/r/ZhIfiiGgr_1080.png",1080],["https://a.vev.design/r/ZhIfiiGgr_1600.png",1600],["https://a.vev.design/r/ZhIfiiGgr_2100.png",2100]]},"_3FhYmqxQ":{"meta":{"width":853,"height":1280,"description":"image.png"},"src":"https://cdn.vev.design/private/nx4PIJZC5DRvGj91MUsleDCILln2/images/_3FhYmqxQ/2100.jpg","srcset":[["https://cdn.vev.design/private/nx4PIJZC5DRvGj91MUsleDCILln2/images/_3FhYmqxQ/500.jpg",500],["https://cdn.vev.design/private/nx4PIJZC5DRvGj91MUsleDCILln2/images/_3FhYmqxQ/1080.jpg",1080],["https://cdn.vev.design/private/nx4PIJZC5DRvGj91MUsleDCILln2/images/_3FhYmqxQ/2100.jpg",1600],["https://cdn.vev.design/private/nx4PIJZC5DRvGj91MUsleDCILln2/images/_3FhYmqxQ/2100.jpg",2100]]},"aNuySzFkW":{"meta":{"width":713,"height":796,"description":"image.png"},"src":"https://cdn.vev.design/private/nx4PIJZC5DRvGj91MUsleDCILln2/images/aNuySzFkW/2100.jpg","srcset":[["https://cdn.vev.design/private/nx4PIJZC5DRvGj91MUsleDCILln2/images/aNuySzFkW/500.jpg",500],["https://cdn.vev.design/private/nx4PIJZC5DRvGj91MUsleDCILln2/images/aNuySzFkW/2100.jpg",1080],["https://cdn.vev.design/private/nx4PIJZC5DRvGj91MUsleDCILln2/images/aNuySzFkW/2100.jpg",1600],["https://cdn.vev.design/private/nx4PIJZC5DRvGj91MUsleDCILln2/images/aNuySzFkW/2100.jpg",2100]]},"hFf5FHwjM":{"meta":{"width":1600,"height":1066},"src":"https://a.vev.design/r/hFf5FHwjM_2100_jpeg.jpg","srcset":[["https://a.vev.design/r/hFf5FHwjM_300_jpeg.jpg",300],["https://a.vev.design/r/hFf5FHwjM_500_jpeg.jpg",500],["https://a.vev.design/r/hFf5FHwjM_1080_jpeg.jpg",1080],["https://a.vev.design/r/hFf5FHwjM_1600_jpeg.jpg",1600],["https://a.vev.design/r/hFf5FHwjM_2100_jpeg.jpg",2100]]},"ns6ZAda5C":{"meta":{"width":574,"height":788,"description":"image.png"},"src":"https://a.vev.design/r/ns6ZAda5C_2100.png","srcset":[["https://a.vev.design/r/ns6ZAda5C_300.png",300],["https://a.vev.design/r/ns6ZAda5C_500.png",500],["https://a.vev.design/r/ns6ZAda5C_1080.png",1080],["https://a.vev.design/r/ns6ZAda5C_1600.png",1600],["https://a.vev.design/r/ns6ZAda5C_2100.png",2100]]},"sJccsJz7O":{"meta":{"width":1500,"height":2250},"src":"https://a.vev.design/r/sJccsJz7O_2100.jpg","srcset":[["https://a.vev.design/r/sJccsJz7O_300.jpg",300],["https://a.vev.design/r/sJccsJz7O_500.jpg",500],["https://a.vev.design/r/sJccsJz7O_1080.jpg",1080],["https://a.vev.design/r/sJccsJz7O_1600.jpg",1600],["https://a.vev.design/r/sJccsJz7O_2100.jpg",2100]]}},"interactions":[],"pkg":{"w729zbwl":"Sk4l8a1Y7","image":"basic","text":"basic","rectangle":"basic","section":"basic","w73box3z":"prro4JSTK3t","w1bn5r0s80-1477":"p8vPJJ1MbCI","w1c3kqru4r-1p7v":"p9y4TTngH8m"},"menus":{"wnXrADGPq":{"children":[{"settings":{},"link":{"mode":1,"widget":{"name":"About us","page":"dzmMJEvXwR","key":"em-PTp14P6"}},"title":"About us","key":"_YV5bV8upU"},{"settings":{},"link":{"mode":1,"widget":{"name":"Partners","page":"dzmMJEvXwR","key":"eIsk--hEz_"}},"title":"Partners","key":"OO9i_bW4oE"},{"settings":{},"link":{"mode":0,"page":"GbXmvMKqP"},"title":"Press","key":"YTruU8o1Cr"}],"title":"Main menu","key":"wnXrADGPq"}},"primaryMenu":"wnXrADGPq"}